| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Ms. Smigal is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Cokkinides is Program Director, Risk Factor Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Smith is Director of Cancer Screening, American Cancer Society, Atlanta, GA.
Dr. Howe is Executive Director, North American Association of Central Cancer Registries, Springfield, IL.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
In this article, the American Cancer Society (ACS) provides estimates of new breast cancer cases and deaths in 2006 and describes trends in incidence, mortality, and survival for female breast cancer in the United States. These estimates are based on incidence data from the National Cancer Institute (NCI) and the North American Association of Central Cancer Registries, which includes state data from NCI and the National Program of Cancer Registries of the Centers for Disease Control and Prevention and mortality data from the National Center for Health Statistics for the most recent years available (1975 to 2002). This article also shows trends in screening mammography. Approximately 212,920 new cases of invasive breast cancer, 61,980 in situ cases, and 40,970 deaths are expected to occur among US women in 2006. As previously reported, breast cancer incidence rates increased rapidly among women of all races from 1980 to 1987, a period when there was increasing uptake of mammography by a growing proportion of US women, and then continued to increase, but at a much slower rate, from 1987 to 2002. Trends in incidence vary by age, race, socioeconomic status, and stage. The continuing increase in incidence (all stages combined) is limited to White women age 50 and older; recent trends are stable for African American women age 50 and older and White women under age 50 years and are decreasing for African American women under age 50 years. Although incidence rates (all races combined) are substantially higher for women age 50 and older (375.0 per 100,000 females) compared with women younger than 50 years (42.5 per 100,000 females), approximately 23% of breast cancers are diagnosed in women younger than 50 years because those women represent 73% of the female population. For women age 35 and younger, age-specific incidence rates are slightly higher among African Americans compared with Whites but then cross over so that Whites have substantially higher incidence at all later ages. Among women of all races and ages, breast cancer mortality rates declined at an average rate of 2.3% per year between 1990 and 2002, a trend that reflects progress in both early detection and treatment. However, death rates in African American women remain 37% higher than in Whites, despite lower incidence rates. Although, in national surveys, approximately 70% of women age 40 years and older report having had a mammogram in the past 2 years, rates vary by race/ethnicity and are markedly lower among women with lower levels of education, without health insurance, and in recent immigrants. Furthermore, a recent study suggests that the true percentage of women having regular mammography is lower than reported in survey data. Encouraging patients age 40 years and older to have annual mammography and clinical breast exam is the single most important step that clinicians can take to reduce suffering and death from breast cancer. Clinicians should also ensure that patients at high risk of breast cancer are identified and offered appropriate referrals and treatment. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  N. Krieger, J. T. Chen, and P. D. Waterman Decline in US Breast Cancer Rates After the Women's Health Initiative: Socioeconomic and Racial/Ethnic Differentials Am J Public Health, April 1, 2010; 100(S1): S132 - S139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. McBride, B. Lebwohl, D. L. Hershman, and A. I. Neugut Impact of Socioeconomic Status on Extent of Lymph Node Dissection for Colon Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2010; 19(3): 738 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. WANG, C.-S. LIU, C.-F. CHIU, S.-Y. CHIANG, C.-H. WANG, R.-F. WANG, C.-C. LIN, R.-Y. TSAI, and D.-T. BAU Significant Association of DNA Repair Gene Ku80 Genotypes with Breast Cancer Susceptibility in Taiwan Anticancer Res, December 1, 2009; 29(12): 5251 - 5254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Brody, R. Morello-Frosch, A. Zota, P. Brown, C. Perez, and R. A. Rudel Linking Exposure Assessment Science With Policy Objectives for Environmental Justice and Breast Cancer Advocacy: The Northern California Household Exposure Study Am J Public Health, November 1, 2009; 99(S3): S600 - S609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Beslija, J. Bonneterre, H. J. Burstein, V. Cocquyt, M. Gnant, V. Heinemann, J. Jassem, W. J. Kostler, M. Krainer, S. Menard, et al. Third consensus on medical treatment of metastatic breast cancer Ann. Onc., November 1, 2009; 20(11): 1771 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Huo, F. Ikpatt, A. Khramtsov, J.-M. Dangou, R. Nanda, J. Dignam, B. Zhang, T. Grushko, C. Zhang, O. Oluwasola, et al. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer J. Clin. Oncol., September 20, 2009; 27(27): 4515 - 4521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Agurs-Collins, L. Rosenberg, K. Makambi, J. R Palmer, and L. Adams-Campbell Dietary patterns and breast cancer risk in women participating in the Black Women's Health Study Am. J. Clinical Nutrition, September 1, 2009; 90(3): 621 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Zheng, C. A. Loffredo, P. G. Shields, and S. M. Selim Chromosome 9 arm-specific telomere length and breast cancer risk Carcinogenesis, August 1, 2009; 30(8): 1380 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Leow, J. Chesebrough, K. T. Coffman, C. A. Fazenbaker, J. Gooya, D. Weng, S. Coats, D. Jackson, B. Jallal, and Y. Chang Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib Mol. Cancer Ther., August 1, 2009; 8(8): 2131 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rojo, I. Gonzalez-Navarrete, R. Bragado, A. Dalmases, S. Menendez, M. Cortes-Sempere, C. Suarez, C. Oliva, S. Servitja, V. Rodriguez-Fanjul, et al. Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin Clin. Cancer Res., May 15, 2009; 15(10): 3530 - 3539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Harper, J. Lynch, S. C. Meersman, N. Breen, W. W. Davis, and M. C. Reichman Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005) Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 121 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lai, S. A. Myers, M. G. Lawrence, D. M. Odorico, and J. A. Clements Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer Mol. Cancer Res., January 1, 2009; 7(1): 129 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Anderson, P. S. Rosenberg, I. Menashe, A. Mitani, and R. M. Pfeiffer Age-Related Crossover in Breast Cancer Incidence Rates Between Black and White Ethnic Groups J Natl Cancer Inst, December 17, 2008; 100(24): 1804 - 1814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fejerman, E. M. John, S. Huntsman, K. Beckman, S. Choudhry, E. Perez-Stable, E. G. Burchard, and E. Ziv Genetic Ancestry and Risk of Breast Cancer among U.S. Latinas Cancer Res., December 1, 2008; 68(23): 9723 - 9728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Mahoney, T. Bevers, E. Linos, and W. C. Willett Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction CA Cancer J Clin, November 3, 2008; (2008) CA.2008.0016v1. [Abstract] [Full Text]
|
|
|
|
|
|
K.-D. Lee, S.-C. Chen, C. H. Chan, C.-H. Lu, C.-C. Chen, J.-T. Lin, M.-F. Chen, S.-H. Huang, C.-M. Yeh, and M.-C. Chen Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2647 - 2655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Heusner, S. Kuemmel, L. Umutlu, A. Koeninger, L. S. Freudenberg, E. A.M. Hauth, K. R. Kimmig, M. Forsting, A. Bockisch, and G. Antoch Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography J. Nucl. Med., August 1, 2008; 49(8): 1215 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ji, J. Olson, J. Zhang, M. Hildebrandt, L. Wang, J. Ingle, Z. Fredericksen, T. Sellers, W. Miller, J. M. Dixon, et al. Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms Cancer Res., July 15, 2008; 68(14): 5997 - 6005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model J. Ultrasound Med., June 1, 2008; 27(6): 855 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hawsawi, H. Ghebeh, S.-F. Hendrayani, A. Tulbah, M. Al-Eid, T. Al-Tweigeri, D. Ajarim, A. Alaiya, S. Dermime, and A. Aboussekhra Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes Cancer Res., April 15, 2008; 68(8): 2717 - 2725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Huang and M. Bredel Use of Gene Signatures to Improve Risk Estimation in Cancer JAMA, April 2, 2008; 299(13): 1605 - 1606. [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Blank, P.-Y. Wong, R. Lakshmanaswamy, R. Guzman, and S. Nandi Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats PNAS, March 4, 2008; 105(9): 3527 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K.T. Tan, L. K. Tan, K. Yu, P. H. Tan, M. Lee, L. H. Sii, C. Y. Wong, G. H. Ho, A. W.Y. Yeo, P. K.H. Chow, et al. Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer Clin. Cancer Res., January 15, 2008; 14(2): 461 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dotto, M. Kluk, B. Geramizadeh, and F. A. Tavassoli Frequency of Clinically Occult Intraepithelial and Invasive Neoplasia in Reduction Mammoplasty Specimens: A Study of 516 Cases International Journal of Surgical Pathology, January 1, 2008; 16(1): 25 - 30. [Abstract] [PDF]
|
|
|
|
|
|
D. Huo and O. I. Olopade Genetic Testing in Diverse Populations: Are Researchers Doing Enough to Get Out the Correct Message? JAMA, December 26, 2007; 298(24): 2910 - 2911. [Full Text] [PDF]
|
|
|
|
|
|
S. I. Mishra, R. Bastani, C. M. Crespi, L. C. Chang, P. H. Luce, and C. R. Baquet Results of a Randomized Trial to Increase Mammogram Usage among Samoan Women Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2594 - 2604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. E. Hahn, M. L. Bondy, M. Selvan, M. J. Lund, J. M. Liff, E. W. Flagg, L. A. Brinton, P. Porter, J. W. Eley, and R. J. Coates Factors Associated with Advanced Disease Stage at Diagnosis in a Population-based Study of Patients with Newly Diagnosed Breast Cancer Am. J. Epidemiol., November 1, 2007; 166(9): 1035 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bartsch, C. Wenzel, G. Altorjai, U. Pluschnig, R. M. Mader, M. Gnant, R. Jakesz, M. Rudas, C. C. Zielinski, and G. G. Steger Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment Clin. Cancer Res., August 1, 2007; 13(15): 4435 - 4439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. MacKinnon, R. C. Duncan, Y. Huang, D. J. Lee, L. E. Fleming, L. Voti, M. Rudolph, and J. D. Wilkinson Detecting an Association between Socioeconomic Status and Late Stage Breast Cancer Using Spatial Analysis and Area-Based Measures Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 756 - 762. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
